Eleanor J. Murray, ScD

Assistant Professor, Epidemiology - Boston University School of Public Health


I am currently an assistant professor of epidemiology at Boston University School of Public Health. My research is on causal inference methodology for improving evidence-based decision-making by patients, clinicians, and policy makers. I use novel statistical methods to answer comparative effectiveness questions for complex and time-varying treatments using observational data and randomized trials when available, and individual-level simulation modeling when insufficient data exist in the time frame required for decision-making. I am currently applying these methods to a variety of medical conditions including HIV progression, cancer, psychiatric conditions, and cardiovascular disease. I was previously a postdoctoral research fellow in Epidemiology at the Harvard T.H. Chan School of Public Health, working on causal inference for comparative effectiveness and real-world evidence in the HSPH Program on Causal Inference. I have an ScD in Epidemiology and MSc in Biostatistics from Harvard, an MPH in Epidemiology from Columbia Mailman School of Public Health, and a BSc in Biology from McGill University.


  • Harvard School of Public Health, ScD Field of Study: Epidemiology
  • Columbia University School of Public Health, MPH Field of Study: Epidemiology
  • McGill University, BSc Field of Study: Biology
  • Harvard School of Public Health, SM/ScM Field of Study: Biostatistics

Classes Taught

  • SPHEP800
  • SPHPH791


  • Published on 4/6/2021

    Fox MP, D'Agostino McGowan L, James BD, Lessler J, Mehta SH, Murray EJ. Concerns About the Special Article on Hydroxychloroquine and Azithromycin in High-Risk Outpatients With COVID-19. Am J Epidemiol. 2021 04 06; 190(4):491-495. PMID: 32860038.

    Read At: PubMed
  • Published on 3/23/2021

    Lodi S, Freiberg M, Gnatienko N, Blokhina E, Yaroslavtseva T, Krupitsky E, Murray E, Samet JH, Cheng DM. Per-protocol analysis of the ZINC trial for HIV disease among alcohol users. Trials. 2021 03 23; 22(1):226. PMID: 33757560.

    Read At: PubMed
  • Published on 2/27/2021

    Rashid A, Sy KTL, Cabrejas JM, Nichols BE, Bhadelia N, Murray EJ. A clinician's primer on epidemiology for COVID-19. Med (N Y). 2021 Apr 09; 2(4):384-394. PMID: 33681831.

    Read At: PubMed
  • Published on 2/23/2021

    Murray EJ, Mason M, Sparke V, Zimmerman PP. Factors Influencing Health Care Workers' Willingness to Respond to Duty during Infectious Disease Outbreaks and Bioterrorist Events: An Integrative Review. Prehosp Disaster Med. 2021 Jun; 36(3):321-337. PMID: 33618789.

    Read At: PubMed
  • Published on 2/17/2021

    Murray EJ, Marshall BDL, Buchanan AL. Emulating Target Trials to Improve Causal Inference from Agent-Based Models. Am J Epidemiol. 2021 Feb 17. PMID: 33595053.

    Read At: PubMed
  • Published on 1/27/2021

    Laubach ZM, Murray EJ, Hoke KL, Safran RJ, Perng W. A biologist's guide to model selection and causal inference. Proc Biol Sci. 2021 01 27; 288(1943):20202815. PMID: 33499782.

    Read At: PubMed
  • Published on 1/21/2021

    D'Agostino McGowan L, Grantz KH, Murray E. Quantifying Uncertainty in Infectious Disease Mechanistic Models. Am J Epidemiol. 2021 Jan 21. PMID: 33475686.

    Read At: PubMed
  • Published on 1/4/2021

    Murray EJ. Editorial: Demystifying the Placebo Effect. Am J Epidemiol. 2021 01 04; 190(1):2-9. PMID: 32719871.

    Read At: PubMed
  • Published on 1/1/2021

    Tennant PWG, Murray EJ. The Quest for Timely Insights into COVID-19 Should not Come at the Cost of Scientific Rigor. Epidemiology. 2021 01; 32(1):e2. PMID: 33065609.

    Read At: PubMed
  • Published on 1/1/2021

    Murray EJ, Caniglia EC, Petito L. . Causal survival analysis: a guide to estimating intention-to-treat and per-protocol effects from randomized clinical trials with non-adherence. Research Methods in Medicine & Health Sciences. 2021; 2(1):39-49.

News & In the Media